Simplex Trading’s 9 Meters Biopharma NMTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,500
Closed -$1K 10557
2022
Q4
$1K Buy
+1,500
New +$3.42K ﹤0.01% 9019
2022
Q3
Sell
-530
Closed -$2K 11252
2022
Q2
$2K Sell
530
-630
-54% -$5.94K ﹤0.01% 9477
2022
Q1
$13K Sell
1,160
-15,210
-93% -$208K ﹤0.01% 8698
2021
Q4
$320K Buy
16,370
+14,040
+603% +$314K ﹤0.01% 4465
2021
Q3
$51K Buy
2,330
+135
+6% +$3.18K ﹤0.01% 7493
2021
Q2
$48K Buy
2,195
+2,159
+5,997% +$53K ﹤0.01% 7690
2021
Q1
$85K Buy
36
+30
+500% +$922 ﹤0.01% 5966
2020
Q4
$9K Buy
+6
New +$100 ﹤0.01% 7494
2019
Q1
Hold
0
-$1K 8091
2018
Q4
Sell
-4
Closed -$296 6826
2018
Q3
$58K Buy
+4
New +$687 ﹤0.01% 5033
2018
Q2
Hold
0
5959

Other funds holding NMTR

Simplex Trading's NMTR Position: Q4 2021 in Review

Simplex Trading sold out of 9 Meters Biopharma (NMTR) in Q4 2021, closing a stake of 20 shares — an estimated $447 sold.

Simplex Trading first reported a position in NMTR in Q3 2018 and held it in 7 quarters. The position peaked at $32K in Q3 2018. 104 funds tracked by Wall St. Rank hold NMTR as of Q4 2021.

  • Simplex Trading reported no remaining 9 Meters Biopharma position as of Q4 2021 after selling out during the quarter.
  • Simplex Trading sold 20 9 Meters Biopharma shares in Q4 2021, an estimated $447.
  • Simplex Trading first reported a position in 9 Meters Biopharma in Q3 2018 and held it in 7 quarters.
  • Simplex Trading's 9 Meters Biopharma position peaked at $32K in Q3 2018.
  • 104 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q4 2021.

Based on Simplex Trading's 13F filing for Q4 2021, filed 4 Feb 2022.